Clinical trials: Mirogabalin

Pain Associated With Fibromyalgia

Treatment of Pain Associated With Fibromyalgia

• Completed
• Age: 18 years and older
• Phase 3
• Results posted

The main objective of this trial is to compare change in weekly average daily pain score (ADPS) from baseline to Week 13 in participants receiving either dose of DS-5565 versus placebo.

Trial name

NCT02187159

Testing

DS-5565, Pregabalin

Where

176 sites in United States, Australia and 10 more

Volunteers

1,270 people

Sponsor

Daiichi Sankyo